Romano Kathryn's Form 4 filing
Krystal Biotech, Inc. (KRYS) · filed Feb 11, 2026
- Accession no.
- 0001711279-26-000011
- Filed
- Feb 11, 2026
- Trade date
- Feb 9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.40M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Romano KathrynCIK 0001801385 | Officer (Chief Accounting Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Common Stock | MOption exerciseAcquired | +12,500 | $63.55 | +$794,375 | 31,818 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −2,000 | $270.56F2 | −$541,120 | 29,818 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −5,700 | $271.66F3 | −$1,548,462 | 24,118 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −2,824 | $272.51F4 | −$769,568.24 | 21,294 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −928 | $273.71F5 | −$254,002.88 | 20,366 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −552 | $274.64F6 | −$151,601.28 | 19,814 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −400 | $275.68F7 | −$110,272 | 19,414 | Direct | |
| Feb 9, 2026 | Common Stock | SSaleDisposed | −96 | $277.88F8 | −$26,676.48 | 19,318 | Direct | |
| Feb 9, 2026 | Common Stock | GGiftDisposed | −750 | $0.00 | $0 | 18,568 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 12,500 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The transaction was executed in multiple trades ranging from $270.010 to $270.950. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F3
The transaction was executed in multiple trades ranging from $271.105 to $272.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F4
The transaction was executed in multiple trades ranging from $272.1275 to $273.070. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F5
The transaction was executed in multiple trades ranging from $273.160 to $274.095. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F6
The transaction was executed in multiple trades ranging from $274.305 to $274.815. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F7
The transaction was executed in multiple trades ranging from $275.445 to $275.930. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Referenced by the price of 1 transaction in Table I.
- F8
The transaction was executed in a single trade.
Referenced by the price of 1 transaction in Table I.